Published in Br J Gen Pract on February 01, 2010
Interventions to reduce primary care delay in cancer referral: a systematic review. Br J Gen Pract (2011) 1.15
Diagnosis: shifting the ROC curve. Br J Gen Pract (2012) 0.75
The White Paper: a framework for survival? Br J Gen Pract (2010) 0.75
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol (2007) 9.57
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst (2002) 9.45
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer (2009) 5.61
Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer (2004) 4.06
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer (2003) 3.89
The National Awareness and Early Diagnosis Initiative in England: assembling the evidence. Br J Cancer (2009) 3.80
Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res (2005) 2.81
Cancer diagnosis in primary care. Br J Gen Pract (2010) 2.24
Completeness of cancer registration: a new method for routine use. Br J Cancer (2000) 1.75
Cancer survival statistics should be viewed with caution. Lancet Oncol (2007) 1.02
Recent trends in cancer mortality in the UK. Br J Cancer (2005) 0.83
Health co-benefits of policies to tackle climate change. Lancet (2010) 1.90
Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial. Br J Haematol (2008) 1.46
Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood (2002) 1.08
Governance of research that uses identifiable personal data. BMJ (2006) 0.94
The impact of privacy and confidentiality laws on the conduct of clinical trials. Clin Trials (2008) 0.85
Professor Robert Souhami [interview]. Eur J Cancer (2002) 0.75
A randomised comparison of radical radiotherapy with or without chemotherapy for patients with non-small lung cancer: results from the Big Lung Trial. Radiother Oncol (2005) 0.75